SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-13-012201
Filing Date
2013-02-25
Accepted
2013-02-25 16:08:52
Documents
2
Period of Report
2013-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K HEPLISAV(TM) CRL rrd371588.htm 8-K 12906
2 DYNAVAX RECEIVES FDA COMPLETE RESPONSE LETTER ON HEPLISAV(TM) BIOLOGIC LICENSE A rrd371588_39291.htm EX-99 7301
  Complete submission text file 0001181431-13-012201.txt   21308
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 13639064
SIC: 2834 Pharmaceutical Preparations